Geneos Wealth Management Inc. Bio Xcel Therapeutics, Inc. Transaction History

Geneos Wealth Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 May 19, 2021	SELL	$42.46 - $56.58 $6,369 - $8,487	-150 Closed	0 $0
Q3 2020 Sep 07, 2021	BUY	$37.44 - $64.63 $1,872 - $3,231	50 Added 50.0%	150 $6,000
Q1 2020 Sep 07, 2021	BUY	$12.26 - $41.14 $1,226 - $4,114	100 New	100 $2,000
Q4 2019 Sep 07, 2021	SELL	$4.05 - $14.61 $870 - $3,141	-215 Closed	0 $0
Q3 2019 Sep 07, 2021	BUY	$7.04 - $11.77 $105 - $176	15 Added 7.5%	215 $1,000
Q1 2019 Sep 07, 2021	BUY	$3.49 - $10.47 $698 - $2,094	200 New	200 $1,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $16.5M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.